These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10637365)
21. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease. Shao D; Zou C; Luo C; Tang X; Li Y Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease. Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494 [TBL] [Abstract][Full Text] [Related]
23. The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis. Sugimoto H Chem Biol Interact; 2008 Sep; 175(1-3):204-8. PubMed ID: 18577377 [TBL] [Abstract][Full Text] [Related]
24. Donepezil: an important prototype to the design of new drug candidates for Alzheimer's disease. Rodrigues Simões MC; Dias Viegas FP; Moreira MS; de Freitas Silva M; Riquiel MM; da Rosa PM; Castelli MR; dos Santos MH; Soares MG; Viegas C Mini Rev Med Chem; 2014 Jan; 14(1):2-19. PubMed ID: 24251806 [TBL] [Abstract][Full Text] [Related]
25. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease. Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408 [TBL] [Abstract][Full Text] [Related]
26. 3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates. Dvir H; Wong DM; Harel M; Barril X; Orozco M; Luque FJ; Muñoz-Torrero D; Camps P; Rosenberry TL; Silman I; Sussman JL Biochemistry; 2002 Mar; 41(9):2970-81. PubMed ID: 11863435 [TBL] [Abstract][Full Text] [Related]
27. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives. Zhang S; Hou B; Yang H; Zuo Z Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327 [TBL] [Abstract][Full Text] [Related]
28. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Duysen EG; Li B; Darvesh S; Lockridge O Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids. Zurek E; Szymański P; Mikiciuk-Olasik E Drug Res (Stuttg); 2013 Mar; 63(3):137-44. PubMed ID: 23447117 [TBL] [Abstract][Full Text] [Related]
30. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease. Son M; Park C; Rampogu S; Zeb A; Lee KW Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. Badia A; Baños JE; Camps P; Contreras J; Görbig DM; Muñoz-Torrero D; Simón M; Vivas NM Bioorg Med Chem; 1998 Apr; 6(4):427-40. PubMed ID: 9597187 [TBL] [Abstract][Full Text] [Related]
37. The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors. Ariel N; Ordentlich A; Barak D; Bino T; Velan B; Shafferman A Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):95-102. PubMed ID: 9742217 [TBL] [Abstract][Full Text] [Related]
38. [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease]. Takatori Y Yakugaku Zasshi; 2006 Aug; 126(8):607-16. PubMed ID: 16880719 [TBL] [Abstract][Full Text] [Related]
39. [Advances in search for acetylcholinesterase inhibitor based on the double active sites hypothesis]. Jin GY; Xia Y; Bai DL Yao Xue Xue Bao; 2002 Sep; 37(9):749-52. PubMed ID: 12567905 [No Abstract] [Full Text] [Related]
40. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease. Crismon ML Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]